Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-309

7 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 51655-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Rosuvastatin calcium, depicting the molecular arrangement with calcium ions (Ca2+) indicated as part of the compound.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A Kaplan-Meier cumulative incidence plot comparing Rosuvastatin calcium (20 mg) labeled as Rsuva and placebo over a 5-year period. The y-axis shows cumulative incidence percentage and the x-axis shows years. Numbers at risk decrease over time for both groups. The figure includes a hazard ratio (HR 0.56, 95% CI 0.46-0.69) and a statistically significant p-value (P<0.001).*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A data table presenting the number of events for various cardiovascular end points comparing Rosuvastatin calcium 20 mg with placebo, including hazard ratios with 95% confidence intervals and P values. End points listed include primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization, accompanied by a hazard ratio forest plot.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A box plot chart comparing the percent change from baseline in LDL-C levels across different doses of four statin drugs: Rosuvastatin (10, 20, 40 mg), Atorvastatin (10, 20, 40, 80 mg), Simvastatin (10, 20, 40, 80 mg), and Pravastatin (10, 20, 40 mg). The y-axis shows percent change with values ranging from 0 to -75, illustrating the LDL-C lowering effect of each dosage.*
FDA Label Image
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Label (51655 309 52 Rev A 03 23 Nhc)

Label (51655 309 52   Rev A 03 23 Nhc)
Label for Rosuvastatin calcium 20 mg film-coated tablets, containing 30 tablets. The label states it is a prescription drug, for oral use, and includes storage instructions to keep between 20°-25°C (68°-77°F) and protect from moisture. It is labeled by Northwind Health Company, LLC with NDC 51655-309-52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.